Uma N. Sundram, MD, PhD

Publication Details

  • CD163 Expression Is Present in Cutaneous Histiocytomas but Not in Atypical Fibroxanthomas AMERICAN JOURNAL OF CLINICAL PATHOLOGY Sachdev, R., Robbins, J., Kohler, S., Vanchinathan, V., Schwartz, E. J., Surdram, U. N. 2010; 133 (6): 915-921


    CD163, a hemoglobin scavenger receptor, is expressed in monocytes and macrophages. Recent work has shown that this marker is specific for neoplasms of histiocytic differentiation. Our aim was to test the ability of CD163 to separate cutaneous histiocytomas from their morphologic mimics. We tested the expression of CD163 in 78 cases, including 19 xanthogranulomas, 16 atypical fibroxanthomas, 6 reticulohistiocytomas, 8 epithelioid cell histiocytomas, 9 cases of Langerhans cell histiocytosis, 10 xanthomas, and 10 intradermal Spitz nevi. CD163 expression was seen in all xanthogranulomas and reticulohistiocytomas, 4 epithelioid cell histiocytomas, 2 cases of Langerhans cell histiocytosis, and 8 xanthomas but was absent in atypical fibroxanthomas and Spitz nevi. CD163 is an excellent marker for confirming histiocytic differentiation and is useful in eliminating morphologic mimics such as Spitz nevi from the differential diagnosis. The lack of CD163 in atypical fibroxanthomas argues against a histiocytic origin for this tumor.

    View details for DOI 10.1309/AJCP88IRBPXQZYIR

    View details for Web of Science ID 000277846700013

    View details for PubMedID 20472850

Stanford Medicine Resources:

Footer Links: